-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OwozZZcPLKvwROIpiDB521WbFgjwrDGk0i/h+ElWv1zN/SuOL7NcVLjfDtpbEoxE LflU2hka19OmKP6LrE9SOA== 0001140361-08-014471.txt : 20080605 0001140361-08-014471.hdr.sgml : 20080605 20080605182526 ACCESSION NUMBER: 0001140361-08-014471 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080605 FILED AS OF DATE: 20080605 DATE AS OF CHANGE: 20080605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearce Homer L CENTRAL INDEX KEY: 0001368009 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 08884075 BUSINESS ADDRESS: BUSINESS PHONE: 317 733 0116 MAIL ADDRESS: STREET 1: 84 CLIFDEN CITY: ZIONSVILLE STATE: IN ZIP: 46077 4/A 1 doc1.xml FORM 4/A X0202 4/A 2008-06-05 2008-06-05 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001368009 Pearce Homer L C/O SUNESIS PHARMACEUTICALS, INC. 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Non-Qualified Stock Option (right to buy) 1.77 2008-06-05 4 A 0 10000 0 A 2008-07-05 2018-06-05 Common Stock 10000 10000 D Exercise price of the derivative security was erroneously listed at $1.76 per share. 1/12th of the shares subject to the option will vest monthly commencing on June 5, 2008, such that 100% of the shares subject to the option will be fully vested and exercisable on June 5, 2009. /s/ Camille L. Acayan, as attorney-in-fact for Homer L. Pearce 2008-06-05 -----END PRIVACY-ENHANCED MESSAGE-----